Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bile duct cancer, Biliary tree cancers, Gallbladder cancer, Secondary cancers
Closed
Phase 3
This trial is looking at adding pembrolizumab to chemotherapy for cancer of the bile duct or gallbladder (the biliary tract).
It is for people whose cancer:
has spread into surrounding tissues and they can’t have surgery to remove it
has spread elsewhere in the body
This is advanced cancer.
Recruitment start: 28 July 2020
Recruitment end: 14 May 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr John Bridgewater
Merck Sharp & Dohme
Last reviewed: 14 July 2021
CRUK internal database number: 16686